NEW YORK, May 27, 2026, 18:07 EDT
Hawkins, Inc. shares traded higher Wednesday, with the Nasdaq stock last seen at $158.64, up $1.70. Investors had weighed growth in the chemical supplier’s water-treatment segment against higher costs from deals. The most recent trade, according to market data, was at 5:35 p.m. EDT.
Ticker action turned positive as U.S. stocks pushed to new highs. The S&P 500 was just above flat, up less than 0.1%. The Dow rose 0.4%, while the Nasdaq Composite edged 0.1% higher. Profitable mid-cap industrial and materials stocks got a lift.
Hawkins is still trading on its May 13 fiscal 2026 report. Sales were up 11% to roughly $1.1 billion. Water Treatment sales climbed 22%, and now make up half the company’s total revenue. Adjusted EBITDA went up 6% to $179.0 million.
Patrick H. Hawkins, CEO and president, called fiscal 2026 “another milestone year.” He credited the “disciplined M&A strategy” with growing Water Treatment and said the company is “well positioned” for fiscal 2027.
The move in the stock didn’t come from a straightforward earnings beat. Diluted earnings per share dropped to $3.91 for the year from $4.03, with higher acquisition amortization, interest costs and earnout expenses dragging on results. An earnout is a payout on an acquisition that depends on performance later.
Deal volume is key to the bull case here. Hawkins picked up WaterSurplus in April 2025, paying around $149.9 million up front and booking a $43.0 million present value for a potential earnout. The company’s fiscal 2026 cash outlay for acquisitions was $167.1 million, according to the 10-K.
Hawkins has a near-term dividend on the table. Google Finance put the ex-dividend date at May 29, which means buyers after that won’t get the next payout. Hawkins said its board approved a 19-cent quarterly dividend, payable June 12 to shareholders who are on the books at the close that day.
Peers traded mixed. Ecolab, the bigger water and hygiene firm, gained 3.3%. On the flip side, Ashland and Dow both dropped, down 0.9% and 2.2%. Hawkins’ stock looked to be moving on its own story, not just in line with the chemicals group.
Analyst coverage is still light. StockAnalysis notes Hamed Khorsand at BWS Financial kept a Strong Buy and $200 target on March 23. Raymond James analyst Bobby Zolper is at Hold. A price target is where analysts think the stock might trade in the next 12 months.
Hawkins is still picking up smaller water-treatment businesses. On April 30, the company said it acquired Aqua-Chem assets—expanding its presence in Nebraska and Iowa. The deal brings in commercial pool chemistry, equipment and service customers.
The downside risk is clear. Hawkins in its annual report cautioned that raw-material costs can change fast, and tariffs or trade barriers might push up costs and slow deliveries. Supply-chain or shipping delays could also hurt margins if Hawkins can’t push price increases to customers quickly enough.
Wednesday is shaping up as a test for how much credit investors are still giving Hawkins for its water-treatment growth, even with acquisition costs, debt, and price swings still in the mix. The stock’s next moves may depend less on index moves and more on whether the 2026 deal push can actually deliver on earnings instead of just revenue.
